LungHealth Unified

It’s time for an integrated approach to lung disease

Lung Health remains one of the most urgent—and solvable—public health challenges, underscoring a persistent and unmet need.

LungHealth, Unified recognizes shared risks, pathways, and solutions across lung cancer and chronic obstructive pulmonary disease (COPD) to advance:

  • Earlier detection
  • Evidence-based therapy
  • Equitable access across communities

An integrated approach closes care gaps across the lung health journey—from risk identification to diagnosis, treatment, and long-term management.

AstraZeneca is reimagining the future of lung care

AstraZeneca is working alongside health systems, providers, quality and therapy leaders, policymakers, and advocates to close the most persistent gaps in lung care so patients are diagnosed earlier, treated more effectively, and supported throughout their care journey.

Speak Up for COPD

AstraZeneca is a proud supporter of the Speak Up for COPD coalition, campaigning to establish COPD as a public health priority and advance policy changes by amplifying the voices of patients and the COPD community to drive change alongside policymakers and healthcare decision makers.


LungXperience

LungXperience makes lung health education tangible and accessible with a mobile tour that brings vital information directly to communities at events like NASCAR races, NHRA drag race events and state fairs. In 2025, AstraZeneca began partnering with the American Lung Association to enable participants to connect with trained respiratory health professionals and registered nurses, who provide personalized, one-on-one support.
 

LungHealth, Unified Overview Fact Sheet


References:

1. National Cancer Institute. Cancer Stat Facts: Lung and Bronchus Cancer. Accessed February 20, 2026. https://seer.cancer.gov/statfacts/html/lungb.html

2. American Cancer Society. Latest ACS Lung Cancer Data: Only 1 in 5 Eligible Adults in U.S. Screened for Lung Cancer; 62,000 Lives Over 5 Years Could be Saved if All Eligible Screened. Accessed February 20, 2026. https://pressroom.cancer.org/2025-lung-cancer-data

3. Mamary AJ, Stewart JI, Kinney GL, et al. Race and Gender Disparities are Evident in COPD Underdiagnoses Across all Severities of Measured Airflow Obstruction. Chronic Obstr Pulm Dis. 2018;5(3):177-184. Published 2018 Jul 2. doi:10.15326/jcopdf.5.3.2017.0145

4. Centers for Disease Control and Prevention. Chronic Obstructive Pulmonary Disease in Adults Age 18 and Older: United States, 2023 Accessed February 20, 2026. https://www.cdc.gov/nchs/data/databriefs/db529.pdf

5. Sharif R, Cuevas CR, Wang Y, Arora M, Sharma G. Guideline adherence in management of stable chronic obstructive pulmonary disease. Respir Med. 2013;107(7):1046-1052. doi:10.1016/j.rmed.2013.04.001

6. Centers for Disease Control and Prevention. Rural COPD Burden. Accessed February 20, 2026. https://www.cdc.gov/rural-health/php/public-health-strategy/public-health-strategies-for-copd-burden.html

7. Centers for Disease Control and Prevention. Cancer Prevention: Rural Policy Brief. Accessed February 20, 2026. https://www.cdc.gov/rural-health/php/policy-briefs/cancer-policy-brief.html